Skip to content
healthcare.dev
Get a free key

Biktarvy

NDC 61958-2501, bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate, tablet, from Gilead Sciences, Inc..

Product NDC
61958-2501
Status
Listed
Labeler
Gilead Sciences, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA210251
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61958-2501 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BICTEGRAVIR SODIUM50 mg/1
  • EMTRICITABINE200 mg/1
  • TENOFOVIR ALAFENAMIDE FUMARATE25 mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleosides [CS]; Nucleosides [CS]

Package NDCNDC-11Package
61958-2501-16195825010130 TABLET in 1 BOTTLE, PLASTIC (61958-2501-1)
61958-2501-2619582501027 TABLET in 1 BOTTLE, PLASTIC (61958-2501-2)
61958-2501-36195825010330 TABLET in 1 BLISTER PACK (61958-2501-3)
61958-2501-56195825010530 TABLET in 1 BLISTER PACK (61958-2501-5)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/664cb8f0-1f65-441b-b0d9-ba3d798be309

  • NADAC price for package 61958250101

    GET /v1/drugs/nadac/61958250101

  • NADAC price for package 61958250103

    GET /v1/drugs/nadac/61958250103

Use it

Look up 61958-2501 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61958-2501 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61958-2501. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.